CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-09 | Boyd Peter E. See Remark | Shares withheld for taxes | −7,681 | $2.65 | $20K | 303,323 |
| 2025-03-09 | Barber Daniel President and CEO | Shares withheld for taxes | −53,998 | $2.65 | $143K | 1,015,173 |
| 2025-03-07 | Barber Daniel President and CEO | Grant or award · Performance Stock Units | +293,100 | 293,100 | ||
| 2025-03-07 | Boyd Peter E. Chief People Officer | Grant or award · Performance Stock Units | +60,000 | 60,000 | ||
| 2025-03-07 | Jung Cassie Chief Operating Officer | Grant or award · Performance Stock Units | +60,000 | 60,000 | ||
| 2025-03-07 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award · Performance Stock Units | +82,500 | 82,500 | ||
| 2025-03-07 | Korczynski Sherry Chief Commercial Officer | Grant or award · Performance Stock Units | +67,500 | 67,500 | ||
| 2025-03-07 | BRAENDER LORI J Corporate Secretary | Grant or award · Performance Stock Units | +82,500 | 82,500 | ||
| 2025-03-07 | Wargacki Stephen Chief Science Officer | Grant or award | +115,000 | 376,414 | ||
| 2025-03-07 | Wargacki Stephen Chief Science Officer | Shares withheld for taxes | −12,859 | $2.65 | $34K | 363,555 |
| 2025-03-07 | Wargacki Stephen Chief Science Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2025-03-07 | Jung Cassie Chief Operating Officer | Grant or award | +80,000 | 313,066 | ||
| 2025-03-07 | Jung Cassie Chief Operating Officer | Shares withheld for taxes | −7,361 | $2.65 | $20K | 305,705 |
| 2025-03-07 | Jung Cassie Chief Operating Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2025-03-07 | TOTH A ERNEST JR Chief Financial Officer | Grant or award | +110,000 | 358,295 | ||
| 2025-03-07 | TOTH A ERNEST JR Chief Financial Officer | Shares withheld for taxes | −10,193 | $2.65 | $27K | 348,102 |
| 2025-03-07 | TOTH A ERNEST JR Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-03-07 | Kraus Carl N Chief Medical Officer | Grant or award | +70,000 | 321,681 | ||
| 2025-03-07 | Kraus Carl N Chief Medical Officer | Shares withheld for taxes | −8,115 | $2.65 | $22K | 313,566 |
| 2025-03-07 | Kraus Carl N Chief Medical Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +30,000 | 30,000 |
Page 6 of 24 · 462 trades